OrbiMed’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-118,600
Closed -$11.9M 161
2015
Q1
$11.9M Buy
118,600
+25,000
+27% +$1.67M 0.1% 96
2014
Q4
$4.91M Buy
+93,600
New +$2.75M 0.05% 110

OrbiMed's ASPX Position: Q2 2015 in Review

OrbiMed sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 118,600 shares — an estimated $11.9M sold.

OrbiMed first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $11.9M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • OrbiMed reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • OrbiMed sold 118,600 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $11.9M.
  • OrbiMed first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • OrbiMed's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $11.9M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on OrbiMed's 13F filing for Q2 2015, filed 14 Aug 2015.